Cargando…
CCL5 might be a prognostic biomarker and associated with immuno-therapeutic efficacy in cancers: A pan-cancer analysis
PURPOSE: Chemokine ligand 5 (CCL5), a vital member of the CC chemokine family, plays diverse roles in tumorigenesis, metastasis, and prognosis in various human tumors. However, no pan-cancer analysis has been conducted to illustrate its distinctive effects on clinical prognosis via underlying mechan...
Autores principales: | Huang, Yanchun, Wu, Lijuan, Sun, Yong, Li, Jiwen, Mao, Nan, Yang, Yeqing, Zhao, Ming, Ren, Sichong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375802/ https://www.ncbi.nlm.nih.gov/pubmed/37519664 http://dx.doi.org/10.1016/j.heliyon.2023.e18215 |
Ejemplares similares
-
Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role
por: Zhu, Hua, et al.
Publicado: (2021) -
Potential value of PRKDC as a therapeutic target and prognostic biomarker in pan-cancer
por: Yang, Xiawei, et al.
Publicado: (2022) -
Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
por: Xu, Yingting, et al.
Publicado: (2023) -
GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer
por: Chen, Guoming, et al.
Publicado: (2022) -
PTBPs: An immunomodulatory-related prognostic biomarker in pan-cancer
por: Chen, Chen, et al.
Publicado: (2022)